• Billboard-Tom-2013
    Billboard-Tom-2013
  • ClinicalTrialsParticipant-Carol
    ClinicalTrialsParticipant-Carol
  • 0007
    0007
  • 322x
    322x
  • 308x
    308x
  • 0221x
    0221x
  • 0095x
    0095x
  • 0090x
    0090x
  • 0029x
    0029x
  • 0001x
    0001x
  • 0026x
    0026x

The Nebraska Cancer Research Center

Since 1984, The Nebraska Cancer Research Center has been a leader in cancer research, providing local access to National Cancer Institute-sponsored cancer clinical trials. Over 1,900 volunteers have participated in treatment, prevention and control trials through NCRC, helping to identify more effective cancer treatments and improve the quality of life of cancer patients.

New Clinical Trials

View all clinical trials available at NCRC.

S1300: Non-Squamous Cell Lung Cancer - A Randomized, Phase II Trial of Crizotinib Plus Pemetrexed Versus Pemetrexed Monotherapy in ALK-Positive Non-Squamous NSCLC Patients Who Have Progressed Systematically After Previous Clinical Benefit From Crizotinib Monotherapy.

S1406:  Metastatic Colorectal Cancer - A Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer.

RU2214081: Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Neuropathy and Paclitaxel-induced Acute Pain Syndrome

Alliance A081105: Non-small Cell Lung Cancer - Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)